951 results on '"Hartmann, Karin"'
Search Results
2. Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
3. Diagnostik und Therapie der systemischen Mastozytose
4. Association between short-term pollen exposure and blood pressure in adults: A repeated-measures study
5. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
6. Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review of the literature
7. Individual Actions in Collective Processes and Forms: Collaboration for Change Across Education, Practice and Public Debate?
8. Mastozytose bei Kindern
9. Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
10. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
11. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
12. Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis
13. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry
14. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
15. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
16. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
17. DIE BÜHNE DEN ARCHITEKTINNEN
18. Delayed‐type hypersensitivity reaction to oral intake of trometamol
19. Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
20. Kindliche Mastozytose
21. Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
22. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
23. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
24. Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
25. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
26. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
27. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
28. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
29. Allergic Contact Stomatitis
30. Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study.
31. Religion betrifft Schule: Religiöse Pluralität gestalten
32. Establishment of an Innovative Preclinical Mouse Model for Advanced Systemic Mastocytosis
33. Prevalence Of The KIT D816V Mutation In Peripheral Blood (PB) Of Patients With Evidence Of Systemic Mast Cell Activation (MCA): Results Of The Prospective, Multi-centered, Global PROSPECTOR Clinical Trial
34. Reductions in Polypharmacy for Patients with Indolent Systemic Mastocytosis on Avapritinib
35. Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study
36. Exploring the Spectrum of Indolent Systemic Mastocytosis: Analysis of High-Risk Disease Features in the PIONEER Study
37. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
38. History and Current Status of Mastocytosis Research in the European Competence Network on Mastocytosis
39. Skin Disease in Mastocytosis
40. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis
41. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
42. Management of Hypersensitivity Reactions to Nondextran Iron Products: New Insights Into Predisposing Risk Factors
43. Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
44. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
45. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
46. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
47. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
48. TNF alpha promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
49. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
50. Occupational anaphylaxis—Data from the anaphylaxis registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.